Valuation Update With 7 Day Price Move • Jun 17
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹120, the stock trades at a trailing P/E ratio of 23x. Average trailing P/E is 28x in the Capital Markets industry in India. Total returns to shareholders of 191% over the past three years. New Risk • Jun 01
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 9.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (₹607.9m market cap, or US$6.41m). Minor Risks Paying a dividend despite being loss-making. Share price has been volatile over the past 3 months (9.3% average weekly change). Profit margins are more than 30% lower than last year (9.0% net profit margin). Revenue is less than US$5m (₹337m revenue, or US$3.5m). Reported Earnings • May 31
Full year 2026 earnings released: EPS: ₹5.23 (vs ₹16.07 in FY 2025) Full year 2026 results: EPS: ₹5.23 (down from ₹16.07 in FY 2025). Revenue: ₹336.6m (down 1.4% from FY 2025). Net income: ₹30.3m (down 68% from FY 2025). Profit margin: 9.0% (down from 27% in FY 2025). The decrease in margin was primarily driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has increased by 45% per year, which means it is well ahead of earnings. Annonce • May 30
Elixir Capital Limited Recommends Final Dividend for the Financial Year Ended 31 March, 2026 Elixir Capital Limited at its 32nd Annual General Meeting will consider a final dividend of 12.5% i.e. INR 1.25 per equity share for the financial year ended March 31, 2026, as recommended by the Board of Directors at its meeting held on May 29, 2026, subject to shareholders’ approval. Annonce • May 19
Elixir Capital Limited to Report Q4, 2026 Results on May 29, 2026 Elixir Capital Limited announced that they will report Q4, 2026 results at 12:15 PM, Indian Standard Time on May 29, 2026 Valuation Update With 7 Day Price Move • Apr 07
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹92.99, the stock trades at a trailing P/E ratio of 24.6x. Average trailing P/E is 23x in the Capital Markets industry in India. Total returns to shareholders of 134% over the past three years. Reported Earnings • Feb 15
Third quarter 2026 earnings released: EPS: ₹6.94 (vs ₹1.52 in 3Q 2025) Third quarter 2026 results: EPS: ₹6.94 (up from ₹1.52 in 3Q 2025). Revenue: ₹131.3m (up 134% from 3Q 2025). Net income: ₹40.2m (up 356% from 3Q 2025). Profit margin: 31% (up from 16% in 3Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has increased by 40% per year, which means it is tracking significantly ahead of earnings growth. Annonce • Feb 03
Elixir Capital Limited to Report Q3, 2026 Results on Feb 13, 2026 Elixir Capital Limited announced that they will report Q3, 2026 results at 12:15 PM, Indian Standard Time on Feb 13, 2026 Reported Earnings • Nov 16
Second quarter 2026 earnings released: EPS: ₹2.94 (vs ₹14.41 in 2Q 2025) Second quarter 2026 results: EPS: ₹2.94 (down from ₹14.41 in 2Q 2025). Revenue: ₹105.9m (down 42% from 2Q 2025). Net income: ₹17.1m (down 80% from 2Q 2025). Profit margin: 16% (down from 46% in 2Q 2025). Over the last 3 years on average, earnings per share has increased by 30% per year whereas the company’s share price has increased by 35% per year. Annonce • Nov 07
Elixir Capital Limited to Report Q2, 2026 Results on Nov 14, 2025 Elixir Capital Limited announced that they will report Q2, 2026 results on Nov 14, 2025 Valuation Update With 7 Day Price Move • Oct 30
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to ₹105, the stock trades at a trailing P/E ratio of 10.7x. Average trailing P/E is 26x in the Capital Markets industry in India. Total returns to shareholders of 172% over the past three years. Valuation Update With 7 Day Price Move • Oct 03
Investor sentiment improves as stock rises 22% After last week's 22% share price gain to ₹135, the stock trades at a trailing P/E ratio of 13.7x. Average trailing P/E is 25x in the Capital Markets industry in India. Total returns to shareholders of 286% over the past three years. Upcoming Dividend • Aug 12
Upcoming dividend of ₹1.25 per share Eligible shareholders must have bought the stock before 19 August 2025. Payment date: 25 September 2025. Payout ratio is a comfortable 7.8% and this is well supported by cash flows. Trailing yield: 1.1%. Lower than top quartile of Indian dividend payers (1.3%). In line with average of industry peers (1.2%). New Risk • Aug 05
New major risk - Earnings quality The company has a high level of non-cash earnings. Accrual ratio: 23% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (23% accrual ratio). Market cap is less than US$10m (₹652.0m market cap, or US$7.43m). Minor Risks Profit margins are more than 30% lower than last year (27% net profit margin). Revenue is less than US$5m (₹341m revenue, or US$3.9m). Reported Earnings • Aug 05
Full year 2025 earnings released: EPS: ₹16.07 (vs ₹26.89 in FY 2024) Full year 2025 results: EPS: ₹16.07 (down from ₹26.89 in FY 2024). Revenue: ₹341.4m (up 2.5% from FY 2024). Net income: ₹93.3m (down 40% from FY 2024). Profit margin: 27% (down from 47% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 57% per year but the company’s share price has only increased by 37% per year, which means it is significantly lagging earnings growth. Declared Dividend • Jul 18
Dividend of ₹1.25 announced Dividend of ₹1.25 is the same as last year. Ex-date: 19th August 2025 Payment date: 25th September 2025 Dividend yield will be 1.1%, which is lower than the industry average of 1.3%. Sustainability & Growth Dividend is covered by both earnings (8% earnings payout ratio) and cash flows (64% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 39% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Annonce • Jul 16
Elixir Capital Limited, Annual General Meeting, Aug 26, 2025 Elixir Capital Limited, Annual General Meeting, Aug 26, 2025, at 10:00 Indian Standard Time. Reported Earnings • May 18
Full year 2025 earnings released: EPS: ₹16.07 (vs ₹26.89 in FY 2024) Full year 2025 results: EPS: ₹16.07 (down from ₹26.89 in FY 2024). Revenue: ₹341.6m (up 2.6% from FY 2024). Net income: ₹93.3m (down 40% from FY 2024). Profit margin: 27% (down from 47% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 57% per year but the company’s share price has only increased by 43% per year, which means it is significantly lagging earnings growth. Annonce • May 10
Elixir Capital Limited to Report Q4, 2025 Results on May 16, 2025 Elixir Capital Limited announced that they will report Q4, 2025 results on May 16, 2025 Valuation Update With 7 Day Price Move • Mar 21
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹139, the stock trades at a trailing P/E ratio of 3.4x. Average trailing P/E is 20x in the Capital Markets industry in India. Total returns to shareholders of 255% over the past three years. New Risk • Feb 21
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: ₹860.9m (US$9.94m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (₹860.9m market cap, or US$9.94m). Minor Risk Share price has been volatile over the past 3 months (8.3% average weekly change). Valuation Update With 7 Day Price Move • Feb 14
Investor sentiment deteriorates as stock falls 23% After last week's 23% share price decline to ₹192, the stock trades at a trailing P/E ratio of 4.7x. Average trailing P/E is 21x in the Capital Markets industry in India. Total returns to shareholders of 336% over the past three years. Reported Earnings • Feb 08
Third quarter 2025 earnings released: EPS: ₹1.52 (vs ₹4.06 in 3Q 2024) Third quarter 2025 results: EPS: ₹1.52 (down from ₹4.06 in 3Q 2024). Revenue: ₹56.0m (down 3.2% from 3Q 2024). Net income: ₹8.84m (down 63% from 3Q 2024). Profit margin: 16% (down from 41% in 3Q 2024). The decrease in margin was primarily driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 63% per year but the company’s share price has increased by 76% per year, which means it is tracking significantly ahead of earnings growth. Annonce • Jan 31
Elixir Capital Limited to Report Q3, 2025 Results on Feb 07, 2025 Elixir Capital Limited announced that they will report Q3, 2025 results on Feb 07, 2025 Valuation Update With 7 Day Price Move • Dec 25
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹319, the stock trades at a trailing P/E ratio of 7.4x. Average trailing P/E is 24x in the Capital Markets industry in India. Total returns to shareholders of 451% over the past three years. Valuation Update With 7 Day Price Move • Dec 06
Investor sentiment improves as stock rises 28% After last week's 28% share price gain to ₹291, the stock trades at a trailing P/E ratio of 6.8x. Average trailing P/E is 23x in the Capital Markets industry in India. Total returns to shareholders of 547% over the past three years. New Risk • Nov 30
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.1% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.1% average weekly change). High level of non-cash earnings (21% accrual ratio). Minor Risk Market cap is less than US$100m (₹1.32b market cap, or US$15.7m). Valuation Update With 7 Day Price Move • Nov 21
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹214, the stock trades at a trailing P/E ratio of 5x. Average trailing P/E is 23x in the Capital Markets industry in India. Total returns to shareholders of 431% over the past three years. Reported Earnings • Nov 15
Second quarter 2025 earnings released: EPS: ₹14.41 (vs ₹5.40 in 2Q 2024) Second quarter 2025 results: EPS: ₹14.41 (up from ₹5.40 in 2Q 2024). Revenue: ₹181.6m (up 200% from 2Q 2024). Net income: ₹83.6m (up 167% from 2Q 2024). Profit margin: 46% (down from 52% in 2Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 44% per year but the company’s share price has increased by 64% per year, which means it is tracking significantly ahead of earnings growth. Annonce • Nov 08
Elixir Capital Limited to Report Q2, 2025 Results on Nov 13, 2024 Elixir Capital Limited announced that they will report Q2, 2025 results on Nov 13, 2024 Valuation Update With 7 Day Price Move • Nov 04
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹162, the stock trades at a trailing P/E ratio of 4.8x. Average trailing P/E is 25x in the Capital Markets industry in India. Total returns to shareholders of 293% over the past three years. New Risk • Oct 23
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: ₹829.6m (US$9.87m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (₹829.6m market cap, or US$9.87m). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (8.2% average weekly change). Annonce • Oct 17
Situation Has Changed Announces Resignation of Radhika Mehta as Chief Financial Officer Elixir Capital Limited at its board of directors meeting held on October 15, 2024, approved change in designation of Mrs. Radhika Mehta from Whole Time Director & Chief Financial Officer to Whole Time Director of the Company with effect from 15 October, 2024. In other words, Mrs. Radhika Mehta has resigned as Chief Financial Officer of the Company with effect from 15 October, 2024 but will continue to act as Whole Time Director of the Company. Mrs. Radhika Mehta was re-appointed as Whole Time Director & Chief Financial Officer of the Company with effect from 14 August, 2021. In terms of Section 196 of the Companies Act, 2013, her term was fixed for a period of 5 years i.e. upto 13 August, 2026. As noted above, Mrs. Radhika Mehta has resigned as Chief Financial Officer of the Company with effect from 15 October, 2024. She will continue to act as Whole Time Director of the Company for the remaining period of her tenure i.e. upto 13 August, 2026. Radhika Mehta holds an MMS from the esteemed S.P. Jain Institute, University of Mumbai, and a Diploma in Securities Law from Government Law College. With 30 years of extensive experience in the capital markets, she has held senior roles at HDFC Ltd. and J.M. Financial & Investment Consultancy. Currently, she serves as Director at Elixir Equities Pvt. Ltd., Elixir Wealth Management Pvt. Ltd., and Dipan Mehta Commodities Pvt. Ltd. A past President of the Rotary Club of Queen's Necklace, Radhika has also held leadership roles within the Rotary District. She remains actively involved in philanthropic endeavours and consultative committees. Varon Mehta studied Economics at the University of Warwick, UK, followed by a Master of Science in Economics & Strategy for Business from the prestigious Imperial College, London. He gained valuable experience working in the Fintech Division of Accenture Pie, UK. Now serving as a Director at Elixir Equities Pvt. Ltd., Varun leads fintech and technology-driven projects, in addition to managing the financial operations of the group. Valuation Update With 7 Day Price Move • Oct 07
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to ₹157, the stock trades at a trailing P/E ratio of 4.6x. Average trailing P/E is 25x in the Capital Markets industry in India. Total returns to shareholders of 308% over the past three years. Valuation Update With 7 Day Price Move • Sep 23
Investor sentiment improves as stock rises 23% After last week's 23% share price gain to ₹169, the stock trades at a trailing P/E ratio of 5x. Average trailing P/E is 25x in the Capital Markets industry in India. Total returns to shareholders of 334% over the past three years. Annonce • Aug 27
Elixir Capital Limited Approves Dividend for the Financial Year Ended 31 March 2024 Elixir Capital Limited announced that at its AGM held on 26 August 2024, the shareholders approved dividend on equity shares at 12.5% that is INR 1.25 per equity share for the financial year ended 31 March 2024. Reported Earnings • Aug 14
First quarter 2025 earnings released: EPS: ₹10.94 (vs ₹3.89 in 1Q 2024) First quarter 2025 results: EPS: ₹10.94 (up from ₹3.89 in 1Q 2024). Revenue: ₹145.6m (up 206% from 1Q 2024). Net income: ₹63.5m (up 182% from 1Q 2024). Profit margin: 44% (down from 48% in 1Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has increased by 38% per year, which means it is tracking significantly ahead of earnings growth. Upcoming Dividend • Aug 09
Upcoming dividend of ₹1.25 per share Eligible shareholders must have bought the stock before 16 August 2024. Payment date: 25 September 2024. Payout ratio is a comfortable 4.6% but the company is not cash flow positive. Trailing yield: 1.1%. Within top quartile of Indian dividend payers (1.1%). Lower than average of industry peers (1.4%). Annonce • Jul 31
Elixir Capital Limited to Report Q1, 2025 Results on Aug 13, 2024 Elixir Capital Limited announced that they will report Q1, 2025 results on Aug 13, 2024 Valuation Update With 7 Day Price Move • Jul 26
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₹120, the stock trades at a trailing P/E ratio of 4.5x. Average trailing P/E is 24x in the Capital Markets industry in India. Total returns to shareholders of 142% over the past three years. Declared Dividend • Jul 12
Dividend of ₹1.25 announced Dividend of ₹1.25 is the same as last year. Ex-date: 16th August 2024 Payment date: 25th September 2024 Dividend yield will be 1.2%, which is lower than the industry average of 1.3%. Sustainability & Growth Dividend is covered by earnings (5% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. Earnings per share has grown by 35% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Annonce • Jul 11
Elixir Capital Limited, Annual General Meeting, Aug 26, 2024 Elixir Capital Limited, Annual General Meeting, Aug 26, 2024. Valuation Update With 7 Day Price Move • Jun 05
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ₹108, the stock trades at a trailing P/E ratio of 4x. Average trailing P/E is 19x in the Capital Markets industry in India. Total returns to shareholders of 254% over the past three years. Reported Earnings • May 18
Full year 2024 earnings released: EPS: ₹26.89 (vs ₹4.20 loss in FY 2023) Full year 2024 results: EPS: ₹26.89 (up from ₹4.20 loss in FY 2023). Revenue: ₹331.4m (up ₹297.1m from FY 2023). Net income: ₹156.1m (up ₹180.4m from FY 2023). Profit margin: 47% (up from net loss in FY 2023). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has increased by 52% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • May 16
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹91.98, the stock trades at a trailing P/E ratio of 9.2x. Average trailing P/E is 23x in the Capital Markets industry in India. Total returns to shareholders of 226% over the past three years. Valuation Update With 7 Day Price Move • Mar 29
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹88.35, the stock trades at a trailing P/E ratio of 8.9x. Average trailing P/E is 22x in the Capital Markets industry in India. Total returns to shareholders of 222% over the past three years. Annonce • Mar 21
Elixir Capital Limited Announces Board Changes The Board Meeting of the Elixir Capital Limited was held on 21 March, 2024, approved the Appointment of Mr. Shail Kapadia as an Independent Director (Additional Director) for a term of 5 years with effect from 1st April, 2024 in place of Mr. Dilip Kapadia, Independent Director. Mr. Shail Kapadia is a qualified practicing Chartered Accountant. He has taken over the role of expanding the firm Specialization in Money Laundering Frauds, Employee Frauds, Bank Frauds and ASM's Experience in Internal Audits across various Sectors such as Manufacturing, Service Sector, Ports, Textiles, Hospitality, etc. which help in understanding the nerves of business functions. He has 6 years' experience of various industry sectors in field of Audits such as Forensics Audits, Process Audits and Internal Audits Mr. Dilip Kapadia has completed his second term as an Independent Director of the Company on 31st March, 2024. Accordingly, he shall cease to be an Independent Director of the Company. Valuation Update With 7 Day Price Move • Feb 21
Investor sentiment improves as stock rises 22% After last week's 22% share price gain to ₹84.25, the stock trades at a trailing P/E ratio of 8.5x. Average trailing P/E is 24x in the Capital Markets industry in India. Total returns to shareholders of 216% over the past three years. Reported Earnings • Feb 14
Third quarter 2024 earnings released: EPS: ₹4.06 (vs ₹1.77 loss in 3Q 2023) Third quarter 2024 results: EPS: ₹4.06 (up from ₹1.77 loss in 3Q 2023). Net income: ₹23.6m (up ₹33.9m from 3Q 2023). Over the last 3 years on average, earnings per share has fallen by 32% per year but the company’s share price has increased by 35% per year, which means it is well ahead of earnings. Annonce • Feb 03
Elixir Capital Limited to Report Q3, 2024 Results on Feb 13, 2024 Elixir Capital Limited announced that they will report Q3, 2024 results on Feb 13, 2024 New Risk • Jan 25
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (33% accrual ratio). Market cap is less than US$10m (₹452.7m market cap, or US$5.45m). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (7.8% average weekly change). Profit margins are more than 30% lower than last year (24% net profit margin). Revenue is less than US$5m (₹101m revenue, or US$1.2m). Valuation Update With 7 Day Price Move • Jan 25
Investor sentiment improves as stock rises 29% After last week's 29% share price gain to ₹78.01, the stock trades at a trailing P/E ratio of 18.9x. Average trailing P/E is 23x in the Capital Markets industry in India. Total returns to shareholders of 192% over the past three years. New Risk • Nov 20
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 24% Last year net profit margin: 37% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). High level of non-cash earnings (33% accrual ratio). Market cap is less than US$10m (₹321.1m market cap, or US$3.86m). Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (24% net profit margin). Revenue is less than US$5m (₹101m revenue, or US$1.2m). Annonce • Oct 31
Elixir Capital Limited to Report Q2, 2024 Results on Nov 09, 2023 Elixir Capital Limited announced that they will report Q2, 2024 results on Nov 09, 2023 Valuation Update With 7 Day Price Move • Oct 18
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹57.21, the stock trades at a trailing P/E ratio of 7x. Average trailing P/E is 24x in the Capital Markets industry in India. Total returns to shareholders of 162% over the past three years. Valuation Update With 7 Day Price Move • Sep 15
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to ₹56.87, the stock trades at a trailing P/E ratio of 6.9x. Average trailing P/E is 23x in the Capital Markets industry in India. Total returns to shareholders of 136% over the past three years. Annonce • Aug 27
Elixir Capital Limited Approves Dividend for the Financial Year Ended 31 March 2023 Elixir Capital Limited announced that at its AGM held on 26 August 2023, the shareholders approved dividend on equity shares at 12.5% that is INR 1.25 per equity share for the financial year ended 31 March 2023. Upcoming Dividend • Aug 11
Upcoming dividend of ₹1.25 per share at 2.7% yield Eligible shareholders must have bought the stock before 18 August 2023. Payment date: 25 September 2023. The company is not currently making a profit but it is cash flow positive. Trailing yield: 2.7%. Within top quartile of Indian dividend payers (1.4%). Higher than average of industry peers (2.0%). Reported Earnings • Aug 07
Full year 2023 earnings released: ₹4.20 loss per share (vs ₹16.54 profit in FY 2022) Full year 2023 results: ₹4.20 loss per share (down from ₹16.54 profit in FY 2022). Net loss: ₹24.4m (down 125% from profit in FY 2022). Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has only increased by 14% per year, which means it is significantly lagging earnings growth. Annonce • Aug 04
Elixir Capital Limited Recommends Final Dividend for the Financial Year Ended March 31, 2023 Elixir Capital Limited announced that at its Twenty - Ninth Annual General Meeting (29th AGM) of the Members to be held on 26 August, 2023, proposed to declare dividend on Equity Shares @ 12.5% that is INR 1.25 per Equity Share for the financial year ended 31 March, 2023 and in this regard, if thought fit, pass the following resolution as an ORDINARY RESOLUTION: "RESOLVED THAT pursuant to the recommendation of the Board of Directors of the Company, dividend on equity shares @ 12.5% that is INR 1.25 per equity share, (as recommended by Board of Directors) be declared and paid out of the accumulated profits for the financial year ended at 31 March, 2023. Annonce • Jul 30
Elixir Capital Limited, Annual General Meeting, Aug 26, 2023 Elixir Capital Limited, Annual General Meeting, Aug 26, 2023, at 10:00 Indian Standard Time. Annonce • Jul 23
Elixir Capital Limited to Report Q1, 2024 Results on Aug 11, 2023 Elixir Capital Limited announced that they will report Q1, 2024 results on Aug 11, 2023 Reported Earnings • Jun 04
Full year 2023 earnings released: ₹4.20 loss per share (vs ₹16.54 profit in FY 2022) Full year 2023 results: ₹4.20 loss per share (down from ₹16.54 profit in FY 2022). Net loss: ₹24.4m (down 125% from profit in FY 2022). Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth. Annonce • Jun 01
Elixir Capital Limited Recommends Final Dividend for the Financial Year Ended March 31, 2023 Elixir Capital Limited at its board meeting held on May 30, 2023, recommended Final Dividend of 12.50% (INR 1.25 per equity share) for the financial year ended March 31, 2023 subject To Approve the shareholders at the 29th Annual General Meeting. Annonce • May 20
Elixir Capital Limited to Report Q4, 2023 Results on May 30, 2023 Elixir Capital Limited announced that they will report Q4, 2023 results on May 30, 2023 Valuation Update With 7 Day Price Move • Apr 11
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to ₹41.80, the stock trades at a trailing P/E ratio of 5.5x. Average trailing P/E is 19x in the Capital Markets industry in India. Total returns to shareholders of 24% over the past three years. Reported Earnings • Feb 01
Third quarter 2023 earnings released: ₹1.77 loss per share (vs ₹0.04 profit in 3Q 2022) Third quarter 2023 results: ₹1.77 loss per share (down from ₹0.04 profit in 3Q 2022). Net loss: ₹10.3m (down ₹10.5m from profit in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 56% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth. Annonce • Jan 15
Elixir Capital Limited to Report Q3, 2023 Results on Jan 30, 2023 Elixir Capital Limited announced that they will report Q3, 2023 results on Jan 30, 2023 Board Change • Nov 16
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 1 experienced director. 3 highly experienced directors. Independent Non Executive Director Suril Shah was the last director to join the board, commencing their role in 2015. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Oct 18
First half 2023 earnings released: EPS: ₹57.96 (vs ₹8.05 in 1H 2022) First half 2023 results: EPS: ₹57.96 (up from ₹8.05 in 1H 2022). Net income: ₹336.3m (up ₹289.6m from 1H 2022). Over the last 3 years on average, earnings per share has increased by 63% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth. Annonce • Oct 08
Elixir Capital Limited to Report Q2, 2023 Results on Oct 17, 2022 Elixir Capital Limited announced that they will report Q2, 2023 results on Oct 17, 2022 Upcoming Dividend • Aug 11
Upcoming dividend of ₹1.25 per share Eligible shareholders must have bought the stock before 18 August 2022. Payment date: 23 September 2022. Payout ratio is a comfortable 7.6% and this is well supported by cash flows. Trailing yield: 2.8%. Within top quartile of Indian dividend payers (1.7%). Higher than average of industry peers (2.3%). Reported Earnings • Aug 04
Full year 2022 earnings released: EPS: ₹16.54 (vs ₹15.72 in FY 2021) Full year 2022 results: EPS: ₹16.54 (up from ₹15.72 in FY 2021). Revenue: ₹226.0m (up 21% from FY 2021). Net income: ₹96.0m (up 5.2% from FY 2021). Profit margin: 43% (down from 49% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 100% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Jul 21
Investor sentiment deteriorated over the past week After last week's 17% share price decline to ₹45.35, the stock trades at a trailing P/E ratio of 2.7x. Average trailing P/E is 18x in the Capital Markets industry in India. Total returns to shareholders of 45% over the past three years. Annonce • Jul 09
Elixir Capital Limited to Report Q1, 2023 Results on Jul 18, 2022 Elixir Capital Limited announced that they will report Q1, 2023 results on Jul 18, 2022 Valuation Update With 7 Day Price Move • Jun 08
Investor sentiment improved over the past week After last week's 19% share price gain to ₹56.10, the stock trades at a trailing P/E ratio of 3.4x. Average trailing P/E is 17x in the Capital Markets industry in India. Total returns to shareholders of 89% over the past three years. Annonce • May 28
Elixir Capital Limited Recommends Final Dividend for the Financial Year Ended 31 March, 2022 Elixir Capital Limited the Board Meeting of the Company was held on 26 May, 2022. The Board of Directors at their Board Meeting recommended final dividend of 12.50% (INR 1.25 per equity share) for the financial year ended 31 March, 2022 subject To Approve the shareholders at the 28th Annual General Meeting. Annonce • May 27
Elixir Capital Limited Announces Executive Changes Elixir Capital Limited at the Board Meeting of the Company was held on 26th May, 2022. As per the recommendation of Nomination and Remuneration Committee and on expiry of present term of Mr. Dipan Mehta as Chairman and Whole-Time Director on 31 May, 2022, the Board of Directors at their Board Meeting appointed Mr. Dipan Mehta as Non-Executive Chairman of the Company effective from 01 June, 2022. Annonce • May 10
Elixir Capital Limited to Report Q4, 2022 Results on May 26, 2022 Elixir Capital Limited announced that they will report Q4, 2022 results on May 26, 2022 Board Change • Apr 27
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 1 experienced director. 3 highly experienced directors. Independent Non Executive Director Suril Shah was the last director to join the board, commencing their role in 2015. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Valuation Update With 7 Day Price Move • Apr 12
Investor sentiment improved over the past week After last week's 16% share price gain to ₹47.85, the stock trades at a trailing P/E ratio of 4.3x. Average trailing P/E is 17x in the Capital Markets industry in India. Total returns to shareholders of 43% over the past three years. Valuation Update With 7 Day Price Move • Jan 28
Investor sentiment deteriorated over the past week After last week's 17% share price decline to ₹48.15, the stock trades at a trailing P/E ratio of 2.6x. Average trailing P/E is 17x in the Capital Markets industry in India. Total returns to shareholders of 50% over the past three years. Valuation Update With 7 Day Price Move • Dec 28
Investor sentiment improved over the past week After last week's 18% share price gain to ₹57.25, the stock trades at a trailing P/E ratio of 3.1x. Average trailing P/E is 16x in the Capital Markets industry in India. Total returns to shareholders of 73% over the past three years. Valuation Update With 7 Day Price Move • Dec 13
Investor sentiment improved over the past week After last week's 16% share price gain to ₹49.45, the stock trades at a trailing P/E ratio of 2.7x. Average trailing P/E is 16x in the Capital Markets industry in India. Total returns to shareholders of 56% over the past three years. Upcoming Dividend • Aug 10
Upcoming dividend of ₹1.25 per share Eligible shareholders must have bought the stock before 17 August 2021. Payment date: 24 September 2021. Trailing yield: 2.6%. Within top quartile of Indian dividend payers (1.4%). Higher than average of industry peers (1.6%). Reported Earnings • Jul 04
Full year 2021 earnings released: EPS ₹15.72 (vs ₹6.61 loss in FY 2020) The company reported a soft full year result with weaker revenues and profit margins, although earnings were improved. Full year 2021 results: Revenue: ₹186.1m (down 3,499% from FY 2020). Net income: ₹91.2m (up ₹129.6m from FY 2020). Profit margin: 49% (down from 700% in FY 2020). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 47% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Jun 18
Investor sentiment improved over the past week After last week's 33% share price gain to ₹46.05, the stock trades at a trailing P/E ratio of 7.1x. Average trailing P/E is 16x in the Capital Markets industry in India. Total returns to shareholders of 26% over the past three years. Is New 90 Day High Low • Mar 02
New 90-day high: ₹30.35 The company is up 14% from its price of ₹26.60 on 02 December 2020. The Indian market is up 16% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Capital Markets industry, which is up 12% over the same period. Reported Earnings • Feb 12
Third quarter 2021 earnings released: EPS ₹5.61 (vs ₹1.67 in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: ₹67.8m (up 162% from 3Q 2020). Net income: ₹32.6m (up 237% from 3Q 2020). Profit margin: 48% (up from 37% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 61% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings. Annonce • Jan 20
Elixir Capital Limited to Report Q3, 2021 Results on Feb 10, 2021 Elixir Capital Limited announced that they will report Q3, 2021 results on Feb 10, 2021 Is New 90 Day High Low • Jan 05
New 90-day high: ₹29.50 The company is up 9.0% from its price of ₹27.00 on 07 October 2020. The Indian market is up 20% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Capital Markets industry, which is up 17% over the same period. Valuation Update With 7 Day Price Move • Dec 07
Market bids up stock over the past week After last week's 17% share price gain to ₹29.05, the stock is trading at a trailing P/E ratio of 30.8x, up from the previous P/E ratio of 26.3x. This compares to an average P/E of 14x in the Capital Markets industry in India. Total return to shareholders over the past three years is a loss of 19%. Reported Earnings • Nov 16
Second quarter 2021 earnings released: EPS ₹1.60 The company reported a soft second quarter result with weaker revenues and profit margins, although earnings were improved. Second quarter 2021 results: Revenue: ₹27.0m (down 961% from 2Q 2020). Net income: ₹9.26m (up ₹18.6m from 2Q 2020). Profit margin: 34% (down from 298% in 2Q 2020). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 106% per year but the company’s share price has only fallen by 16% per year, which means it has not declined as severely as earnings. Is New 90 Day High Low • Nov 10
New 90-day low: ₹22.25 The company is down 21% from its price of ₹28.15 on 12 August 2020. The Indian market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Capital Markets industry, which is up 3.0% over the same period. 